Neural stem cell transplantation in central nervous system disorders: From cell replacement to neuroprotection

Donatella De Feo, Arianna Merlini, Cecilia Laterza, Gianvito Martino

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Purpose of Review: Transplantation of neural stem/precursor cells (NPCs) has been proposed as a promising therapeutic strategy in almost all neurological disorders characterized by the failure of central nervous system (CNS) endogenous repair mechanisms in restoring the tissue damage and rescuing the lost function. Nevertheless, recent evidence consistently challenges the limited view that transplantation of these cells is solely aimed at protecting the CNS from inflammatory and neurodegenerative damage through cell replacement. Recent Findings: Recent preclinical data confirmed that transplanted NPCs may also exert a 'bystander' neuroprotective effect and identified a series of molecules-for example, immunomodulatory substances, neurotrophic growth factors, stem cell regulators as well as guidance molecules-whose in-situ secretion by NPCs is temporally and spatially orchestrated by environmental needs. A better understanding of the molecular and cellular mechanisms sustaining this 'therapeutic plasticity' is of pivotal importance for defining crucial aspects of the bench-to-beside translation of neural stem cell therapy, that is route and timing of administration as well as the best cellular source. Further insight into those latter issues is eagerly expected from the ongoing phase I/II clinical trials, while, on the other hand, new cellular sources are being developed, mainly by exploiting the new possibilities offered by cellular reprogramming. Summary: Nowadays, the research on NPC transplantation in neurological disorders is advancing on two different fronts: on one hand, recent preclinical data are uncovering the molecular basis of NPC therapeutic plasticity, offering a more solid rational framework for the design of clinical studies. On the other hand, pilot trials are highlighting the safety and feasibility issues of neural stem cell transplantation that need to be addressed before efficacy could be properly evaluated.

Original languageEnglish
Pages (from-to)322-333
Number of pages12
JournalCurrent Opinion in Neurology
Volume25
Issue number3
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Neural Stem Cells
Central Nervous System Diseases
Stem Cell Transplantation
Nervous System Diseases
Central Nervous System
Bystander Effect
Phase II Clinical Trials
Clinical Trials, Phase I
Cell Transplantation
Nerve Growth Factors
Neuroprotective Agents
Cell- and Tissue-Based Therapy
Neuroprotection
Intercellular Signaling Peptides and Proteins
Stem Cells
Therapeutics
Transplantation
Safety
Research

Keywords

  • Bystander effect
  • Cell replacement
  • Neural stem/precursor cells
  • Neurodegeneration
  • Neuroinflammation
  • Therapeutic plasticity

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Neural stem cell transplantation in central nervous system disorders : From cell replacement to neuroprotection. / De Feo, Donatella; Merlini, Arianna; Laterza, Cecilia; Martino, Gianvito.

In: Current Opinion in Neurology, Vol. 25, No. 3, 06.2012, p. 322-333.

Research output: Contribution to journalArticle

@article{9abaa16d173a41d090a7268c101207c9,
title = "Neural stem cell transplantation in central nervous system disorders: From cell replacement to neuroprotection",
abstract = "Purpose of Review: Transplantation of neural stem/precursor cells (NPCs) has been proposed as a promising therapeutic strategy in almost all neurological disorders characterized by the failure of central nervous system (CNS) endogenous repair mechanisms in restoring the tissue damage and rescuing the lost function. Nevertheless, recent evidence consistently challenges the limited view that transplantation of these cells is solely aimed at protecting the CNS from inflammatory and neurodegenerative damage through cell replacement. Recent Findings: Recent preclinical data confirmed that transplanted NPCs may also exert a 'bystander' neuroprotective effect and identified a series of molecules-for example, immunomodulatory substances, neurotrophic growth factors, stem cell regulators as well as guidance molecules-whose in-situ secretion by NPCs is temporally and spatially orchestrated by environmental needs. A better understanding of the molecular and cellular mechanisms sustaining this 'therapeutic plasticity' is of pivotal importance for defining crucial aspects of the bench-to-beside translation of neural stem cell therapy, that is route and timing of administration as well as the best cellular source. Further insight into those latter issues is eagerly expected from the ongoing phase I/II clinical trials, while, on the other hand, new cellular sources are being developed, mainly by exploiting the new possibilities offered by cellular reprogramming. Summary: Nowadays, the research on NPC transplantation in neurological disorders is advancing on two different fronts: on one hand, recent preclinical data are uncovering the molecular basis of NPC therapeutic plasticity, offering a more solid rational framework for the design of clinical studies. On the other hand, pilot trials are highlighting the safety and feasibility issues of neural stem cell transplantation that need to be addressed before efficacy could be properly evaluated.",
keywords = "Bystander effect, Cell replacement, Neural stem/precursor cells, Neurodegeneration, Neuroinflammation, Therapeutic plasticity",
author = "{De Feo}, Donatella and Arianna Merlini and Cecilia Laterza and Gianvito Martino",
year = "2012",
month = "6",
doi = "10.1097/WCO.0b013e328352ec45",
language = "English",
volume = "25",
pages = "322--333",
journal = "Current Opinion in Neurology",
issn = "1350-7540",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Neural stem cell transplantation in central nervous system disorders

T2 - From cell replacement to neuroprotection

AU - De Feo, Donatella

AU - Merlini, Arianna

AU - Laterza, Cecilia

AU - Martino, Gianvito

PY - 2012/6

Y1 - 2012/6

N2 - Purpose of Review: Transplantation of neural stem/precursor cells (NPCs) has been proposed as a promising therapeutic strategy in almost all neurological disorders characterized by the failure of central nervous system (CNS) endogenous repair mechanisms in restoring the tissue damage and rescuing the lost function. Nevertheless, recent evidence consistently challenges the limited view that transplantation of these cells is solely aimed at protecting the CNS from inflammatory and neurodegenerative damage through cell replacement. Recent Findings: Recent preclinical data confirmed that transplanted NPCs may also exert a 'bystander' neuroprotective effect and identified a series of molecules-for example, immunomodulatory substances, neurotrophic growth factors, stem cell regulators as well as guidance molecules-whose in-situ secretion by NPCs is temporally and spatially orchestrated by environmental needs. A better understanding of the molecular and cellular mechanisms sustaining this 'therapeutic plasticity' is of pivotal importance for defining crucial aspects of the bench-to-beside translation of neural stem cell therapy, that is route and timing of administration as well as the best cellular source. Further insight into those latter issues is eagerly expected from the ongoing phase I/II clinical trials, while, on the other hand, new cellular sources are being developed, mainly by exploiting the new possibilities offered by cellular reprogramming. Summary: Nowadays, the research on NPC transplantation in neurological disorders is advancing on two different fronts: on one hand, recent preclinical data are uncovering the molecular basis of NPC therapeutic plasticity, offering a more solid rational framework for the design of clinical studies. On the other hand, pilot trials are highlighting the safety and feasibility issues of neural stem cell transplantation that need to be addressed before efficacy could be properly evaluated.

AB - Purpose of Review: Transplantation of neural stem/precursor cells (NPCs) has been proposed as a promising therapeutic strategy in almost all neurological disorders characterized by the failure of central nervous system (CNS) endogenous repair mechanisms in restoring the tissue damage and rescuing the lost function. Nevertheless, recent evidence consistently challenges the limited view that transplantation of these cells is solely aimed at protecting the CNS from inflammatory and neurodegenerative damage through cell replacement. Recent Findings: Recent preclinical data confirmed that transplanted NPCs may also exert a 'bystander' neuroprotective effect and identified a series of molecules-for example, immunomodulatory substances, neurotrophic growth factors, stem cell regulators as well as guidance molecules-whose in-situ secretion by NPCs is temporally and spatially orchestrated by environmental needs. A better understanding of the molecular and cellular mechanisms sustaining this 'therapeutic plasticity' is of pivotal importance for defining crucial aspects of the bench-to-beside translation of neural stem cell therapy, that is route and timing of administration as well as the best cellular source. Further insight into those latter issues is eagerly expected from the ongoing phase I/II clinical trials, while, on the other hand, new cellular sources are being developed, mainly by exploiting the new possibilities offered by cellular reprogramming. Summary: Nowadays, the research on NPC transplantation in neurological disorders is advancing on two different fronts: on one hand, recent preclinical data are uncovering the molecular basis of NPC therapeutic plasticity, offering a more solid rational framework for the design of clinical studies. On the other hand, pilot trials are highlighting the safety and feasibility issues of neural stem cell transplantation that need to be addressed before efficacy could be properly evaluated.

KW - Bystander effect

KW - Cell replacement

KW - Neural stem/precursor cells

KW - Neurodegeneration

KW - Neuroinflammation

KW - Therapeutic plasticity

UR - http://www.scopus.com/inward/record.url?scp=84860729847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860729847&partnerID=8YFLogxK

U2 - 10.1097/WCO.0b013e328352ec45

DO - 10.1097/WCO.0b013e328352ec45

M3 - Article

C2 - 22547103

AN - SCOPUS:84860729847

VL - 25

SP - 322

EP - 333

JO - Current Opinion in Neurology

JF - Current Opinion in Neurology

SN - 1350-7540

IS - 3

ER -